There is a stubborn myth surrounding pregnancy: that any pharmacy pill is automatically dangerous for the baby, and the safest strategy for an expecting mother is to tough out a headache or cold without touching a single capsule. Loud internet "exposés" thrive on this anxiety—all a speaker has to do is flash an English-language table from a medical journal, and any doubt seems out of place. In evidence-based medicine, however, even a legitimate study is easy to twist inside out if you confuse a statistical coincidence with proven harm.
Recently, a wave of short videos swept through parenting group chats, prompting a detailed breakdown by physician Ilya Burlakov on his Telegram channel Borodaty ne proboval.... The clips claim that taking ordinary paracetamol (also known as acetaminophen) during pregnancy damages the reproductive system of future daughters and shrinks their egg reserve. I pulled up the original Danish paper and cross-checked it against European regulators—so let's calmly unpack where those alarming percentages came from and why trying to endure a high fever without medication carries a far greater risk.
Where the "Minus 41%" Came From—and Why There Was Never Any "Before and After"
In the viral video, it sounds like an open-and-shut verdict: taking just 2–3 grams of paracetamol over an entire pregnancy—a modest 4–6 standard 500 mg tablets—supposedly shrinks newborn girls' ovarian volume by 41%, reduces uterus size by 13%, and cuts the number of antral follicles (the tiny fluid-filled sacs where eggs mature) by 23%. To seal the deal, the narrator puts a chart on screen and calls it a "before and after" picture of fetuses and infants exposed to the drug.
Open the actual paper from the Danish COPANA project—led by Margit Fischer and Kasper Hagen at Rigshospitalet in Copenhagen and published in Human Reproduction Open—and the viral sensation falls apart point by point:
- There were no "before and after" measurements. Doctors never performed prenatal ultrasounds of fetal ovaries. Researchers examined 302 healthy girls once, at 3 months of age, and plotted two independent groups: babies whose mothers recalled taking paracetamol during pregnancy, and babies whose mothers didn't.
- Nobody tested the effect of "exactly four tablets." Expecting mothers were not given counted doses in a controlled trial. They simply filled out questionnaires about over-the-counter painkillers, and for most, occasional use over nine months came down to a few doses.
- The dramatic percentage isn't physical organ shrinkage—it's a mathematical projection. In a direct comparison between the two groups of infants without complex statistical adjustments, the difference was less than half as large (under 20%) and didn't even reach statistical significance. The scary number only appeared inside a regression model after adjusting through indirect variables.
- An infant's ovarian size does not predict infertility. During the first months of life, babies go through a natural hormonal surge—mini-puberty—when ovarian volume and the count of follicles visible on ultrasound (2 mm and larger) constantly fluctuate. The Danish authors themselves stated explicitly in the paper: these early measurements say nothing about egg reserve in adulthood, age at menopause, or future fertility.
The Cause-and-Effect Trap: Is the Pill to Blame, or the Illness Itself?
Even if a gap between groups showed up in certain calculations, why can't we pin it directly on paracetamol? Here we hit the main methodological flaw of any observational study where scientists don't assign treatment in controlled conditions, but simply collect questionnaires after the fact.
In evidence-based medicine, this trap is called confounding by indication. Healthy pregnant women don't pop painkillers for fun. An expecting mother reaches for the medicine cabinet when something is already wrong: a splitting migraine hits, a tooth aches, or a viral infection drives up a fever.
In the Danish study, researchers recorded whether a tablet was taken, but never objectively measured how severe or long-lasting the mother's illness was, or how much inflammation was in her body. As a result, the footprint of the medication became hopelessly tangled with the footprint of the illness itself. Blaming paracetamol from data like that is like studying fire statistics and concluding that red fire trucks destroy roofs—because wherever more trucks showed up, more rafters burned down. A developing embryo can be affected by viral toxins, a spike in body temperature, or vascular spasms during a migraine, not by the molecule taken to relieve the pain. We explored how easily coincidence gets mistaken for causation without blinded controls in our piece on why isolated observations without blinded trials often lead to the wrong conclusions.
The Illusion of Multiple Comparisons and the Real Danger of High Fever
On top of mixing up cause and effect, there's another classic pitfall: ignoring multiple comparisons. When scientists measure dozens of different parameters in the same group at once (left and right ovarian volume, uterus dimensions, follicle counts, and a whole panel of blood hormones), probability dictates that at least a couple of lines will show a difference purely by chance.
Imagine tossing a handful of coins twenty times in a row: sooner or later one of them will land heads five times straight, and that doesn't mean the coin is rigged. In the COPANA study, the authors didn't apply a strict correction for multiple testing and openly warned in their limitations section that the finding could easily be a chance result.
The real tragedy is that viral scare stories push pregnant women into a genuinely dangerous trap—enduring fever and exhausting pain out of fear of harming their baby, when solid clinical data says the exact opposite:
- The European regulator's verdict. The Pharmacovigilance Risk Assessment Committee (PRAC) and the European Medicines Agency (EMA) reviewed the body of pregnancy data and confirmed that no causal link has been found between therapeutic doses of paracetamol and birth defects, neurodevelopmental disorders, or reproductive harm. The drug remains the first-line choice for pain and fever at any stage of pregnancy.
- The proven risk of untreated fever. Unlike hypothetical fluctuations on an infant ultrasound, a high maternal fever (hyperthermia above 38.5 °C in the first trimester) directly threatens the developing fetal nervous system. A meta-analysis of 15 studies led by Myla Moretti (1,719 cases of birth defects and 37,898 healthy pregnancies) showed that untreated fever in early pregnancy nearly doubles (1.92 times higher risk) the odds of severe neural tube defects.
That is why modern medicine evaluates medications not by social media clips, but through a strict balance of benefit and risk—a principle born from hard lessons, as we covered in our story on how modern drug safety standards for pregnancy were shaped.
You don't need to take painkillers 'just in case' for minor discomfort during pregnancy. But if your temperature climbs above 38 °C or pain keeps you from sleeping and functioning, a single dose of paracetamol (500–1,000 mg) at the lowest effective dose for a short 1–3 day course, cleared with your doctor, protects both you and your baby.
Used thoughtfully when actually needed, paracetamol remains the safest, best-studied way to bring down a dangerous fever or ease acute pain during pregnancy—while the scary numbers in viral clips reflect nothing more than statistical noise and unmeasured maternal illness.

